About This Cover

Optica
20 August 2016, Volume 3, Issue 8, pp. 793-924

Using an FDA clinically approved dye, an optofluidic laser is demonstrated with serological components, albumins and lipoproteins, as well as in human serum and whole blood.

See Chen et al., pp. 809-815.

See print version of the cover.

Return to issue